From: Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
Mutations epigenetic writer, reader, or eraser enzymes | Epigenetic activity, mutation info Loss of function (LOF) Gain of function (GOF) | References |
DNMT3A, TET2 | DNA (hydroxy)methylation, LOF Reduced overall patient survival | |
ARID1A/2/4A/5B | SWI-SNF chromatin remodelling, LOF | [17] |
CHD2/4 | Chromodomain, missense, frameshift mutations, LOF | [17] |
SETD2/B2 | Histone H3K9 methylase, LOF | [17] |
UTX/KDM6A | Histone H3K27 demethylase, missense mutations, LOF Reduced overall patient survival | |
UTY | Histone H3K27demethylase, LOF | [154] |
EZH2 | Histone H3K27 methylase, LOF | [155] |
MMSET/NSD2/WHSC1 | Histone H3K36K27 (de)methylase, translocation, point mutations, LOF/GOF | |
MLL1/2/3/4/5 | Histone H3K4 methylase, missense/nonsense/frameshift/splice-site mutations, LOF | [53] |
EHMT2 | Histone H3K9 methylase, missense mutations | [17] |
KDM3B | Histone H3K9 demethylase, missense/nonsense/splice-site mutations | [17] |
EP300/CREBBP | Histone acetylase, missense/nonsense/frameshift mutations, LOF | [17] |
Histone mutations | Histone variant | Reference |
HIST1H1B/C/D/E | Core/linker histone, missense mutations, frameshift insertion/deletion mutations | [17] |